Multimodality treatment of gynecomastia in patients receiving antiandrogen therapy for prostate cancer in the era of abiraterone acetate and new antiandrogen molecules.
about
Multimodality treatment of gynecomastia in patients receiving antiandrogen therapy for prostate cancer in the era of abiraterone acetate and new antiandrogen molecules.
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Multimodality treatment of gyn ...... nd new antiandrogen molecules.
@ast
Multimodality treatment of gyn ...... nd new antiandrogen molecules.
@en
Multimodality treatment of gyn ...... nd new antiandrogen molecules.
@nl
type
label
Multimodality treatment of gyn ...... nd new antiandrogen molecules.
@ast
Multimodality treatment of gyn ...... nd new antiandrogen molecules.
@en
Multimodality treatment of gyn ...... nd new antiandrogen molecules.
@nl
prefLabel
Multimodality treatment of gyn ...... nd new antiandrogen molecules.
@ast
Multimodality treatment of gyn ...... nd new antiandrogen molecules.
@en
Multimodality treatment of gyn ...... nd new antiandrogen molecules.
@nl
P2093
P2860
P50
P356
P1433
P1476
Multimodality treatment of gyn ...... and new antiandrogen molecules
@en
P2093
Antonella Palazzo
Daniele Alesini
Emanuela Risi
Enrico Cortesi
Federica Urbano
Roberto Iacovelli
P2860
P356
10.1159/000343821
P577
2012-11-02T00:00:00Z